Education
About Us
Working with TipRanks
Follow Us
Gemina Laboratories Ltd. (TSE:GLAB)
:GLAB
GLAB Stock Chart & Stats
C$0.45
-C$0.02(-2.86%)
At close: 4:00 PM EST
C$0.45
-C$0.02(-2.86%)
Day’s Range― - ―
52-Week RangeC$0.10 - C$1.25
Previous CloseN/A
Volume500.00
Average Volume (3M)8.34K
Market Cap
C$9.95M
Enterprise ValueC$57.67M
Total Cash (Recent Filing)C$14.97K
Total Debt (Recent Filing)C$243.65K
Price to Earnings (P/E)―
Beta-0.89
Next Earnings
Dec 18, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding76,570,910
10 Day Avg. Volume13,505
30 Day Avg. Volume8,341
Financial Highlights & Ratios
PEG Ratio0.42
Price to Book (P/B)-9.02
Price to Sales (P/S)0.00
P/FCF Ratio-30.74
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Gemina Laboratories Ltd. News
GLAB FAQ
What was Gemina Laboratories Ltd.’s price range in the past 12 months?
Gemina Laboratories Ltd. lowest stock price was C$0.10 and its highest was C$1.25 in the past 12 months.
What is Gemina Laboratories Ltd.’s market cap?
Gemina Laboratories Ltd.’s market cap is C$9.95M.
When is Gemina Laboratories Ltd.’s upcoming earnings report date?
Gemina Laboratories Ltd.’s upcoming earnings report date is Dec 18, 2025 which is 3 days ago.
How were Gemina Laboratories Ltd.’s earnings last quarter?
Gemina Laboratories Ltd. released its earnings results on Sep 26, 2025. The company reported -C$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.005.
Is Gemina Laboratories Ltd. overvalued?
According to Wall Street analysts Gemina Laboratories Ltd.’s price is currently Overvalued.
Does Gemina Laboratories Ltd. pay dividends?
Gemina Laboratories Ltd. does not currently pay dividends.
What is Gemina Laboratories Ltd.’s EPS estimate?
Gemina Laboratories Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Gemina Laboratories Ltd. have?
Gemina Laboratories Ltd. has 76,570,910 shares outstanding.
What happened to Gemina Laboratories Ltd.’s price movement after its last earnings report?
Gemina Laboratories Ltd. reported an EPS of -C$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Gemina Laboratories Ltd.?
Currently, no hedge funds are holding shares in TSE:GLAB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Gemina Laboratories Ltd.
Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company develops novel surface functionalization chemistries for the detection of pathogens and biomarkers. It is developing POC Antigen COVID test, a point-of-care lateral flow assay test strip to test whether or not a person is currently infected with COVID-19. The company is headquartered in Vancouver, Canada.
Technical Analysis
Oncolytics Biotech
―
Oncolytics Biotech
―
Covalon Technologies
―
Microbix Biosystms
―
Medmira
―
Sernova
―